World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
22811
World Ranking
3286
National Ranking
150

Pascal Poignard publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pascal Poignard sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 119 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pascal Poignard D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pascal Poignard sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pascal Poignard is affiliated with Grenoble Alpes University in France and has contributed primarily to the field of Medicine, with a focus on Infectious Diseases. Their research spans multiple subfields including Immunology, Virology, Molecular Biology, and Neurology.

The scientist's work extensively covers topics related to SARS-CoV-2 and COVID-19, including clinical research studies, detection and testing methods, and long-term effects of COVID-19. Additional research interests include HIV treatment and malaria control, as well as the role of the complement system in diseases.

Pascal Poignard has published in several scientific venues, frequently contributing to bioRxiv (Cold Spring Harbor Laboratory) with seven publications. Other notable journals where their work appears include Frontiers in Immunology, Scientific Reports, Journal of Infection, and eLife.

Recent publications include the following:

  • Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality, 2021, Frontiers in Immunology
  • Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform, 2022, Molecular Therapy
  • SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy, 2021, Emerging Infectious Diseases
  • Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study, 2021, Scientific Reports
  • AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome, 2022, International Journal of Molecular Sciences

Frequent co-authors in Pascal Poignard's collaborative research efforts include Isabelle Bally, Axelle Amen, Marlyse Buisson, Olivier Épaulard, and Alexandre Gaymard.

The scientist's body of work reflects a focus on viral infectious diseases, immune responses, and molecular mechanisms underlying severe viral infections, particularly COVID-19. Their contributions have appeared in a diverse range of journals and research platforms pertinent to immunology and infectious disease communities.

Best Publications

  • Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

    Laura M. Walker;Sanjay K. Phogat;Po-Ying Chan-Hui;Denise Wagner

  • Broad neutralization coverage of HIV by multiple highly potent antibodies

    Laura M. Walker;Michael Huber;Michael Huber;Katie J. Doores;Katie J. Doores;Emilia Falkowska;Emilia Falkowska

  • Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

    Johannes F. Scheid;Hugo Mouquet;Beatrix Ueberheide;Ron Diskin

  • Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses

    Michela Locci;Michela Locci;Colin Havenar-Daughton;Colin Havenar-Daughton;Elise Landais;Jennifer Wu

  • A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

    Robert Pejchal;Katie J. Doores;Katie J. Doores;Laura M. Walker;Reza Khayat

  • Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

    Melissa D. Simek;Wasima Rida;Frances H. Priddy;Pham Pung

  • Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

    Dan H. Barouch;James B. Whitney;Brian Moldt;Florian Klein

  • Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.

    Ann J Hessell;Pascal Poignard;Meredith Hunter;Lars Hangartner

  • Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

    Ann J. Hessell;Eva G. Rakasz;Pascal Poignard;Pascal Poignard;Lars Hangartner;Lars Hangartner

  • Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses

    Dennis R. Burton;Dennis R. Burton;Pascal Poignard;Robyn L. Stanfield;Ian A. Wilson

  • Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

    Brian Moldt;Eva G. Rakasz;Niccole Schultz;Po-Ying Chan-Hui

  • Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort

    Elise Landais;Xiayu Huang;Colin Havenar-Daughton;Ben Murrell

  • A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

    Laura M. Walker;Melissa D. Simek;Frances Priddy;Johannes S. Gach

  • Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

    Ann J. Hessell;Eva G. Rakasz;David M. Tehrani;Michael Huber

  • Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers

    Emilia Falkowska;Khoa M. Le;Khoa M. Le;Alejandra Ramos;Alejandra Ramos;Katie J. Doores;Katie J. Doores;Katie J. Doores

  • Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1

    Aran F. Labrijn;Pascal Poignard;Aarti Raja;Michael B. Zwick

  • Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.

    Q J Sattentau;J P Moore;F Vignaux;F Traincard

  • Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.

    Jean-Philippe Julien;Devin Sok;Reza Khayat;Jeong Hyun Lee

  • Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

    Claudia Blattner;Jeong Hyun Lee;Kwinten Sliepen;Ronald Derking

  • GP120: Biologic Aspects of Structural Features

    Pascal Poignard;Erica Ollmann Saphire;Paul Whi Parren;Dennis R. Burton

  • IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform.

    N. Lance Hepler;Konrad Scheffler;Steven Weaver;Ben Murrell

Frequent Co-Authors

Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Wayne C. Koff
Wayne C. Koff International AIDS Vaccine Initiative
Ian A. Wilson
Ian A. Wilson Scripps Research Institute
Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Devin Sok
Devin Sok Scripps Research Institute
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Andrew B. Ward
Andrew B. Ward Scripps Research Institute
Katie J. Doores
Katie J. Doores King's College London
Bruce D. Walker
Bruce D. Walker Harvard University
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can expand career opportunities. Nursing pathways, in particular, offer accelerated and accessible options. Many aspiring nurses choose programs like the nurse practitioner accelerated program to fast-track their clinical expertise and leadership roles in healthcare settings.

Those without prior nursing experience can also start with the best online RN programs for non nurses. These programs offer flexible formats that accommodate students transitioning into nursing from other disciplines, complementing foundational knowledge in immunology.

For quicker entry into nursing, many explore the easiest accelerated nursing programs, designed for those aiming to earn their Bachelor of Science in Nursing in less time. Similarly, practical nursing roles can be accessed through the best easiest LPN programs to get into, providing a foundation for patient care with potential to bridge into advanced immunological careers.

Best Scientists Citing Pascal Poignard

Trending Scientists

Recently Published Articles